The Future of Biosimilar Development
By 2030, another 88 biologics will face a loss of exclusivity, representing a market of $100 billion. In this infographic, learn which market factors are spurring manufacturers to invest in developing new biosimilars, according to our 2025 State of Patient Access Survey.
Download the Infographic
Understand the likelihood of biosimilar investment by category.
Learn which factors most influence entry in the biosimilar race.
See the impact of the IRA Biosimilar Delay Provision on development.